Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, Cidara Therapeutics Inc’s stock clocked out at $64.85, up 5.40% from its previous closing price of $61.53. In other words, the price has increased by $5.40 from its previous closing price. On the day, 0.84 million shares were traded. CDTX stock price reached its highest trading level at $66.945 during the session, while it also had its lowest trading level at $61.0.
Ratios:
To gain a deeper understanding of CDTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.87 and its Current Ratio is at 3.87. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
On March 12, 2025, Citizens JMP started tracking the stock assigning a Mkt Outperform rating and target price of $46.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 26 ’25 when RA CAPITAL MANAGEMENT, L.P. bought 2,272,727 shares for $44.00 per share. The transaction valued at 99,999,988 led to the insider holds 3,365,523 shares of the business.
Mineo Chrysa bought 2,270 shares of CDTX for $49,281 on Jun 02 ’25. The Director now owns 2,270 shares after completing the transaction at $21.71 per share. On Jun 03 ’25, another insider, Mineo Chrysa, who serves as the Director of the company, bought 1,050 shares for $23.44 each. As a result, the insider paid 24,614 and bolstered with 3,320 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDTX now has a Market Capitalization of 1507483648 and an Enterprise Value of 675616000. For the stock, the TTM Price-to-Sale (P/S) ratio is 4781.07 while its Price-to-Book (P/B) ratio in mrq is 5.59. Its current Enterprise Value per Revenue stands at 2237.139 whereas that against EBITDA is -6.268.
Stock Price History:
The Beta on a monthly basis for CDTX is 1.18, which has changed by 4.4267783 over the last 52 weeks, in comparison to a change of 0.17774606 over the same period for the S&P500. Over the past 52 weeks, CDTX has reached a high of $62.16, while it has fallen to a 52-week low of $10.14. The 50-Day Moving Average of the stock is 80.33%, while the 200-Day Moving Average is calculated to be 176.14%.
Shares Statistics:
It appears that CDTX traded 645.94K shares on average per day over the past three months and 757840 shares per day over the past ten days. A total of 22.12M shares are outstanding, with a floating share count of 17.49M. Insiders hold about 20.93% of the company’s shares, while institutions hold 47.24% stake in the company. Shares short for CDTX as of 1751241600 were 1609237 with a Short Ratio of 2.49, compared to 1748563200 on 474262. Therefore, it implies a Short% of Shares Outstanding of 1609237 and a Short% of Float of 7.7.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
